Skip to Content

Jubilee Brown, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Director of Gynecologic Oncology at The Woman's Hospital of Texas, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Dr. Jubilee Brown has been a faculty member in the Department of Gynecologic Oncology since 2002, when she completed her fellowship in Gynecologic Oncology at the M.D. Anderson Cancer Center. Dr. Brown sees patients within the Department of Gynecologic Oncology at M.D. Anderson, as well as running the M.D. Anderson satellite office at the Woman’s Hospital of Texas. By integrating care in both of these centers, she is able to offer women with gynecologic cancer and complex gynecologic surgical issues the optimal care in the most appropriate and desired setting.


Dr. Brown has focused her practice on providing comprehensive care for the patient with gynecologic cancer. She sees this journey as a partnership in care with the patient and her family, the referring physician, herself, and the team of caregivers in the health care setting. Dr. Brown is an expert in minimally invasive surgery (laparoscopic surgery and robotic-assisted laparoscopy), as she feels it is important to provide the best surgical option with the least disruption to the patient’s lifestyle. This has revolutionized the care of women over the last few years!


Dr. Brown is very active nationally and internationally, and is considered an expert in the field of rare tumors and minimally invasive surgery. She is active in the Gynecologic Oncology Group, the American Association of Gynecologic Laparoscopists, the Society of Gynecologic Oncologists, and holds national positions in many of these organizations.


Dr. Brown looks forward to partnering with each patient to make this a personalized journey with the best possible outcome for each individual.


Office Address

The University of Texas MD Anderson Cancer Center
P. O. Box 301439
Unit Number: 1362
Houston, TX 77230-1439
Phone: 713-792-1380
Fax: 713-792-3567

Education & Training

Degree-Granting Education

1993 University of Cincinnati, Cincinnati, OH, MD, Medicine
1989 Michigan State University, East Lansing, MI, BS, Magna cum laude, Physiology

Postgraduate Training

7/1999-6/2002 Clinical Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, David M. Gershenson, M.D.
7/1997-6/1999 Post-Residency Training, Gynecologic Oncology, The Gynecologic Oncology Center Mercy Medical Center, Baltimore, MD, Neil B. Rosenshein, M.D. and William P. McGuire, M.D.
7/1994-6/1997 Clinical Residency, Obstetrics and Gynecology, University of Maryland, Baltimore, MD, M. C. Crenshaw, M.D.
7/1993-6/1994 Clinical Internship, Obstetrics and Gynecology, University of Maryland, Baltimore, MD, M. C. Crenshaw, M.D.

Board Certifications

1/2005 American College of Obstetricians and Gynecologists, Gynecologic Oncology
12/2003 American Board of Obstetrics and Gynecology


Academic Appointments

Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, TX, 9/2002-8/2009
Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences, Gynecologic Oncology, The University of Texas Health Science Center Houston, Houston, TX, 7/2002-8/2009
Instructor, Department of Gynecologic Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, 7/1999-9/2002
Instructor, University of Maryland Medical Systems, Baltimore, MD, 7/1997-6/1999

Other Appointments/Responsibilities

Provisional Staff Member, Texas Children's Hospital, Houston, TX, 3/2007-present
Provisional Staff Member, Methodist Hospital, Houston, TX, 11/2006-present
Active Staff Member, The Woman's Hospital of Texas, Houston, TX, 8/2003-present
Active Staff Member, Memorial Hermann Hospital, Houston, TX, 4/2003-present
Active Staff Member, St. Luke's Episcopal Hospital, Houston, TX, 8/2002-present
Active Staff Member, Lyndon Baines Johnson Hospital, Houston, TX, 7/2002-present

Institutional Committee Activities

Member, Faculty Host Advocate, 9/2006-present
Gynecologic Oncology Representative, The Woman's Hospital of Texas Journal Club, 9/2006-present
Co-Chairman, Ovarian Working Group, 9/2006-3/2010
Member, Master of Science Supervisory Committee, 9/2005-9/2009
Member, Health Sciences Research Working Group, 7/2005-present
Member, Fellowship Applications Subcommittee, 7/2004-present
Member, Tumor Bank Committee, 9/2003-present
Member, Physicians Network Quality Management Committee, 9/2003-present
Member, Physicians Network Credentialing Committee, 9/2003-present
Member, Endometrial, Ovarian, and Cervical Cancer Working Groups, 7/2003-6/2009

Honors and Awards

2008 America's Top Obstetricians and Gynecologists, Guide to America's Top Obstetricians and Gynecologists/SJD Industries
2003 Nursing Professional Development & Education Award, M. D. Anderson Cancer Center
2000 AFLAC-AACR Young Investigator Award

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow, 2004-present
American Society of Clinical Oncologists
Member, 2003-present
Castle Medical Education & Development Foundation
Member, 2006-present
Felix Rutledge Society
Member, 2002-present
Female Physicians Organization, Harris County Medical Society
Member, 2003-present
Gynecologic Oncology Group
Member of Rare Tumor Committee, 2005-present
Member Ovarian Committee, 2003-2008
Member, 2002-present
Harris County Medical Society
Member, 2003-present
Houston Gynecological and Obstetrical Society
Member, 2003-present
Intercultural Cancer Council
Member, 2004-present
International Gynecologic Cancer Society
Member, 2004-present
Society of Gynecologic Oncologists
Full Member, 2006-present
Member, 1999-present
Society of Laparoendoscopic Surgeons
Member, 2007-present
Western Association of Gynecologic Oncologists
Member, 2004-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Tao X, Sood AK, Deavers MT, Schmeler KM, Nick AM, Coleman RL, Milojevic L, Gershenson DM, Brown J. Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors. Gynecol Oncol 114(3):431-6, 9/2009. PMID: 19524286.
2. Hobday CD, Milam MR, Milam RA, Euscher E, Brown J.. Postoperative small bowel obstruction associated with the use of hemostatic agents. Journal of Minimally Invasive Gynecology 16(2):224-226, 5/2009. PMID: 19249715.
3. Brown J, Sood AK, Deavers MT, Milojevic L, Gershenson DM. Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted? Gynecol Oncol 113(1):86-90, 4/2009. PMID: 19162310.
4. Gaikwad A, Wolf J, Brown J, Ramondetta LM, Smith J. In vitro evaluation of the effects of gefitinib on the cytotoxic activity of selected anticancer agents in a panel of human endometrial cancer cell lines. J Oncol Pharm Pract 15(1):35-44, 3/2009. PMID: 18753181.
5. Posligua L, Malpica A, Liu J, Brown J, Deavers MT. Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread. Arch Pathol Lab Med 132(11):1821-4, 11/2008. PMID: 18976022.
6. Ramirez PT, Schmeler KM, Wolf JK, Brown J, Soliman PT. Robotic radical parametrectomy and pelvic lymphadenectomy in patients with invasive cervical cancer. Gynecol Oncol 111(1):18-21, 10/2008. PMID: 18639329.
7. Jones KL, Saucier JM, Sun CC, Bevers MW, Ramondetta LM, Brown J, Smith JA. Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics. J Oncol Pharm Pract 14(1):31-6, 3/2008. PMID: 18337438.
8. Navo MA, Smith JA, Gaikwad A, Burke T, Brown J, Ramondetta LM. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemother Pharmacol 62(3):483-9, 11/2007. PMID: 18004570.
9. Smith JA, Gaikwad A, Yu J, Wolf JK, Brown J, Ramondetta LM, Stewart CF. In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines. Cancer Chemother Pharmacol 62(1):51-8, 9/2007. PMID: 17849119.
10. Frumovitz M, dos Reis R, Sun CC, Milam MR, Bevers MW, Brown J, Slomovitz BM, Ramirez PT. Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstet Gynecol 110(1):96-102, 7/2007. PMID: 17601902.
11. Ramondetta LM, Sun C, Hollier L, Jarrett L, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown J. Advanced cervical cancer treatment in Harris County: Pilot evaluation of factors that prevent optimal therapy. Gynecol Oncol 103(2):547-553, 11/2006. PMID: 16730784.
12. Smith JA, Gaikwad A, Ramondetta LM, Wolf JK, Brown J. Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines. Gynecol Oncol 103(2):518-22, 11/2006. PMID: 16690105.
13. Navo M, Kunthur A, Badell ML, Coffer LW, Markman M, Brown J, Smith JA. Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients. Gynecol Oncol 103(2):608-13, 11/2006. PMID: 16797060.
14. Eifel PJ, Jhingran A, Brown J, Levenback C, Thames H. Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer 16:1106-11, 5/2006. PMID: 16803493.
15. Stevens TA, Brown J, Zander DS, Bevers MW, Gershenson DM, Ramondetta LM. Adult granulosa cell tumors of the ovary in two first-degree relatives. Gynecol Oncol 98(3):502-5, 9/2005. PMID: 15992917.
16. Sood AK, Abu-Rustum NR, Barakat RR, Bodurka DC, Brown J, Donato ML, Poynor EA, Wolf JK, Gershenson DM. Fifth International Conference on Ovarian Cancer: challenges and opportunities. Gynecol Oncol 97(3):916-23, 6/2005. PMID: 15907981.
17. Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback C. Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 97(3):840-4, 6/2005. PMID: 15882895.
18. Orejuela FJ, Ramondetta LM, Smith J, Brown J, Lemos LB, Li Y, Hollier LM. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Gynecol Oncol 97(2):483-488, 5/2005. PMID: 15863148.
19. Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 97(2):489-96, 5/2005. PMID: 15863149.
20. Bristol I, Brown J, Slomovitz BM, Shannon VR, Eifel PJ. Methemoglobinemia induced by topical vaginal sulfanilamide cream in a patient with cervical cancer: a case report. Gynecol Oncol 97(3):953-956, 2005. PMID: 15907987.
21. Brown J, Shvartsman HS, Deavers MT, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol 22(17):3517-23, 9/2004. PMID: 15337800.
22. Smith JA, Brown J, Martin MC, Ramondetta LM, Wolf JK. An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell lines. Gynecol Oncol 92(91):314-319, 2004. PMID: 14751176.
23. Brown J, Broaddus R, Koeller M, Burke TW, Gershenson DM, Bodurka DC. Sarcomatoid carcinoma of the cervix. Gynecol Oncol 90(1):23-28, 2003. PMID: 12821337.
24. Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol 100(4):788-95, 10/2002. PMID: 12383550.
25. Robinson JB, Singh D, Bodurka-Bevers DC, Wharton JT, Gershenson DM, Wolf JK. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies. Gynecol Oncol 82:550-558, 9/2001. PMID: 11520154.
26. Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60(19):5334-9, 10/2000. PMID: 11034066.
27. Robinson JB, Sun CC, Bodurka-Bevers D, Im DD, Rosenshein NB. Cavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelial neoplasia. Gynecol Oncol 78(2):235-41, 8/2000. PMID: 10926809.
28. Knox SN, Robinson JB, Im DD, Logan L, Rosenshein NB. The use of paclitaxel and cisplatin in a patient with epithelial ovarian cancer and human immunodeficiency virus. Gynecol Oncol 76(1):118-22, 2000. PMID: 10620453.
29. Robinson JB, Im DD, Logan L, McGuire WP, Rosenshein NB. Extraovarian granulosa cell tumor. Gynecol Oncol 74(1):123-7, 7/1999. PMID: 10385563.
30. Robinson JB, Im DD, Jockle G, Rosenshein NB. Vulvar porokeratosis: case report and review of the literature. Int J Gynecol Pathol 18(2):169-73, 4/1999. PMID: 10202676.
31. Robinson JB, Im DD, Simmons-O'Brien E, Rosenshein NB. Etretinate: therapy for plasma cell vulvitis. Obstet Gynecol 92(4 Pt 2):706, 10/1998. PMID: 9764673.
32. Robinson JB, Morris M. Cervical carcinoma metastatic to the brain. Gynecol Oncol 66(2):324-6, 8/1997. PMID: 9264584.

Invited Articles

1. Wolf J, Brown J. Management of Stromal Tumors of the Ovary. ASCO Educational Book:225-228, 2008.
2. Robinson JB, McGuire WP. Editorial opinion. Abstracts in Hematology and Oncology, 1999.
3. Im ,DD, Robinson JB, Rosenshein NB. The treatment of intraepithelial neoplasia of the lower genital tract with laser surgery. Oper Tech Gynecol Surg 4((3)):1-13, 1999.
4. Robinson, JB, Im DD, Rosenshein NB. Ovarian tumors of low malignant potential. The Gynecology Oncology Center Newsletter 2:1-2, 1998.
Other Articles
1. Brown J. Fallopian tube cancer. Cancer Wise, 2004.


1. Tao X, Sood AK, Deavers MT, Schmeler KM, Nick AM, Coleman RL, Gershenson DM, Brown J. Antiangiogenic therapy for granulosa cell tumors of the ovary. Journal of Clinical Oncology (#5574), May, 31, 2009, 6/2009.
2. Brown J, Deavers MT, Nick AM, Milojevic L, Gershenson DM, Sood AK. Clinical relevance of angiogenesis and lymphangiogenesis in patients with sex cord-stromal ovarian tumors. Journal of Clinical Oncology (#5575), May, 31, 2009, 6/2009.
3. Burzawa JK, Schmeler KM, Soliman PT, Lacour RA, Meyer LA, Bevers MW, Frumovitz MM, Pustilnik TB, Brown J, Anderson ML, Ramondetta LM, Tortolero-Luna G, Gershenson DM, Lu KH. Prospective, population-based evaluation of insulin resistance, polycystic ovary syndrome and metabolic syndrome in a cohort of patients with endometrial cancer. Gynecol Oncol 112(S85), 1/2009.
4. Brown J, Deavers M, Nick A, Milojevic L, Gershenson D, Sood A. VEGF Overexpression and Angiogenesis are Prevalent and Predict Clinical Outcome in Patients with Sex Cord-Stromal Ovarian Tumors. Gynecol Oncol 112(S95), 1/2009.
5. Brown J. Hand-Assisted Laparoscopic Splenectomy. Proceedings of the 37th Annual AAGL Global Congress of Minimally Invasive Gynecology, October 28, 2008, 8/2008.
6. Milam MR, Abaid L, Gehrig PA, dos Reis R, Livasy C, Frumovitz M, Brown J, Broaddus RR, Ramirez PT. Does microscopic nodal count improve detection of nodal metastasis in early stage cervical cancer? : A dual institution review. Gynecol Oncol 552 (#552), 3/2008.

Book Chapters

1. Brown J. Predictive factors in germ cell and stromal tumors of the ovary. In: Prognostic and Predictive Factors in Gynecologic Cancers. Informa UK Ltd: London, 141-151, 2011.
2. Brown J. Female genital tract cancer. In: Cancer Epidemiology in Older Adolescents and Young Adults 15-29 Years of Age, including SEER Incidence and Survival: 1975-2000. NIH Pub. No. 06-5767. Ed(s) A Bleyer, M O'Leary, R Barr, LAG Ries. National Cancer Institute: Bethesda, MD, 163-172, 2006.
3. Brown J, Jhingran A, Deavers M, Markman M. Stromal tumors of the ovary. In: Textbook of Uncommon Cancer. 7, 41. Ed(s) D Raghavan, ML Brecher, DH Johnson, NJ Meropol, PL Moots, PG Rose, IA Mayer. John Wiley and Sons, Ltd: West Sussex UK, 455-466, 2006.
4. Brown, J, Gershenson DM. Treatment for Rare Ovarian Malignancies. In: M. D. Anderson Cancer Care Series Gynecologic Cancer. 13. Ed(s) PJ Eifel, DM Gershenson, JJ Kanavagh, EG Silva. Springer-Verlag: New York, 207-225, 2006.
5. Robinson JB, Im DD, McGuire WP, Rosenshein NB. Aggressive Cytoreductive Surgery versus Conservative Surgery in Advanced Ovarian Cancer. In: Clinical Management of Ovarian Cancer. I Vergote. Martin Dunitz, 2000.
6. Robinson JB, Bodurka-Bevers DC. Cancer of the Endometrium. In: Advances in Medicine. ABI Professional Publications, 581-598, 2000.

Manuals, Teaching Aids, Other Teaching Publications

1. Brown J, Bevers MW, Ramirez PT, Frumovitz M. Hand-Assisted Laparoscopic Splenectomy: Video Presented at the 37th Global Congress of the American Association of Gynecologic Laparoscopy. 37th Global Congress of the American Association of Gynecologic Laparoscopy: Las Vegas, NV, 10/2008.
2. Ramirez PT, Brown J, Frumovitz M. Radical Abdominal Trachelectomy. Video Presented at the 28th Annual Meeting of the Society of Gynecologic Oncologists: San Diego, CA, 3/2007.

Last updated: 6/18/2015